VC firm
NYBC Ventures
- Investor type
- VC
- Assets under management
- $50MStated by firm, as of 2026-09-17Source (opens in a new tab)
Claim, correct or request removal
Record updated 17 September 2026
About
A fund accelerating breakthroughs in blood and cellular therapies and supporting technologies
Investment approach
- Thesis
- Our investment strategy targets promising early to mid stage innovations in blood and cellular therapies and related technologies. We support therapeutics, devices, and other breakthrough solutions that address key challenges in our fields of interest.Source (opens in a new tab)
Loading relationship preview